Loading page content…
Loading page content…
| Source: | Contracts Finder |
| Notice Type: | Pipeline / planning |
| Buyer: | NHS Blood and Transplant (Bristol) |
| Main Category: | Services |
| Procurement Method: | — |
| Tender Status: | Planning |
| Estimated Value (ex. VAT): | £2,400,000 |
| Release Date: | 11 September 2024 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-b5fd17-bc9c1349-7a2d-4237-b74f-53ea3a3e90b8 |
| Notice Reference: | d500181d-db44-41bd-89c0-879ca87b11b3-784570 |
All 2 notices for this procurement, oldest first.
Supply & Maintenance of New & Maintenance of Existing Cell Selection Systems
Earlier notices predate the Procurement Act 2023 (commenced 24 Feb 2025) and therefore don't carry UK1–UK17 codes.
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
This Prior Information Notice (PIN) is separate to any tender opportunity. The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures. The purpose of this notice is to: • Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases. • Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support. Please express your interest by the 2nd October 2024 and direct any questions to tennille.madigan@nhsbt.nhs.uk Additional information: This Prior Information Notice (PIN) is separate to any tender opportunity. The Cellular & Molecular Therapies (CMT) laboratories within NHS Blood and Transplant ( NHSBT) provide a range of services to support haemopoietic stem cell transplantation including collection, processing, and cryopreservation of stem cells. An important part of the services offered by CMT is the purification of stem cells and depletion of other cells, such as CD3+, TCRαβ, CD19+ cells, that may cause complications in the transplant procedures. The purpose of this notice is to: • Alert potential suppliers that NHSBT intends to award a contract for the supply of consumables and maintenance of existing equipment and in addition potential purchase of new equipment & maintenance in the future if demand increases. • Develop NHSBTs understanding of the capabilities, dependencies and competitiveness of the marketplace and the ability of industry to provide the required level of support. Please express your interest by the 2nd October 2024 and direct any questions to tennille.madigan@nhsbt.nhs.uk
Pipeline status
Not addedContract imported automatically · AI writes the response
Estimated Value
£2,400,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →